This Danaos Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
I'm LongbridgeAI, I can summarize articles.Wall Street analysts upgraded five stocks on Thursday: Raymond James upgraded Sabra Health Care REIT to Market Perform; Deutsche Bank upgraded Coupang to Buy with a lowered price target; Freedom Broker upgraded Danaos Corp to Buy, raising its target to $155; Jefferies upgraded J&J Snack Foods to Buy, increasing the target to $101; and JP Morgan upgraded Charles River Labs to Overweight, boosting the target to $310.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Raymond James analyst David Rodgers upgraded Sabra Health Care REIT Inc (NASDAQ:SBRA) from Underperform to Market Perform. Sabra Health Care closed at $21.08 on Wednesday. See how other analysts view this stock.
- Deutsche Bank analyst Peter Milliken upgraded Coupang Inc (NYSE:CPNG) from Hold to Buy and cut the price target from $23 to $21.5. Coupang shares closed at $16.00 on Wednesday. See how other analysts view this stock.
- Freedom Broker analyst Sergey Glinyanov upgraded Danaos Corp (NYSE:DAC) from Hold to Buy and boosted the price target from $140 to $155. Danaos closed at $138.62 on Wednesday. See how other analysts view this stock.
- Jefferies analyst Scott Marks upgraded J&J Snack Foods Corp (NASDAQ:JJSF) from Hold to Buy and raised the price target from $81 to $101. J&J Snack Foods shares closed at $84.66 on Wednesday. See how other analysts view this stock.
- JP Morgan analyst Casey Woodring upgraded Charles River (NYSE:CRL) from Neutral to Overweight and boosted the price target from $180 to $310. Charles River shares closed at $260.72 on Wednesday. See how other analysts view this stock.
Considering buying DAC stock? Here’s what analysts think:
Photo via Shutterstock